Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for iSpecimen Inc. as of June 30, 2025 is 5.91 MM.
- The operating income for iSpecimen Inc. as of June 30, 2025 is -11.01 MM.
- The net income for iSpecimen Inc. as of June 30, 2025 is -10.19 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 5.91 | -11.01 | -10.19 |
2025-03-31 | 8.06 | -11.37 | -11.25 |
2024-12-31 | 9.29 | -12.73 | -12.50 |
2024-09-30 | 10.39 | -9.76 | -9.52 |
2024-06-30 | 10.51 | -10.25 | -10.20 |
2024-03-31 | 9.27 | -11.63 | -11.57 |
2023-12-31 | 9.93 | -11.17 | -11.10 |
2023-09-30 | 10.31 | -10.44 | -10.19 |
2023-06-30 | 10.12 | -11.35 | -11.17 |
2023-03-31 | 10.83 | -10.37 | -10.29 |
2022-12-31 | 10.40 | -10.19 | -10.25 |
2022-09-30 | 9.99 | -10.04 | -10.14 |
2022-06-30 | 10.12 | -8.40 | -8.59 |
2022-03-31 | 10.69 | -7.34 | -7.38 |
2021-12-31 | 11.14 | -5.93 | -8.96 |
2021-09-30 | 11.30 | -4.86 | -8.50 |
2021-06-30 | 10.84 | -4.13 | -8.20 |
2021-03-31 | 9.44 | -2.90 | -6.98 |
2020-12-31 | 8.18 | -2.41 | -4.65 |
2020-09-30 | 6.76 | -2.19 | -4.41 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -17.58 | -17.58 |
2024-09-30 | -17.59 | -17.63 |
2024-06-30 | -21.12 | -21.17 |
2024-03-31 | -25.49 | -25.53 |
2023-12-31 | -24.55 | -24.55 |
2023-09-30 | -22.64 | -22.67 |
2023-06-30 | -24.95 | -24.98 |
2023-03-31 | -23.14 | -23.21 |
2022-12-31 | -23.17 | -23.20 |
2022-09-30 | -23.82 | -23.82 |
2022-06-30 | -21.36 | -21.36 |
2022-03-31 | -23.64 | -23.59 |
2021-12-31 | -41.81 | |
2021-09-30 | -64.76 | -64.76 |
2021-06-30 | -148.37 | -148.37 |
2021-03-31 | -149.06 | -149.06 |
2020-12-31 | -99.38 | |
2020-09-30 | -94.15 | -94.15 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for iSpecimen Inc. as of June 30, 2025 is -5.94 MM.
- The cash from investing activities for iSpecimen Inc. as of June 30, 2025 is -0.25 MM.
- The cash from financing activities for iSpecimen Inc. as of June 30, 2025 is 4.63 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -5.94 | -0.25 | 4.63 |
2025-03-31 | -7.29 | 0.04 | 5.94 |
2024-12-31 | -8.26 | 1.98 | 5.82 |
2024-09-30 | -4.35 | 1.33 | 2.05 |
2024-06-30 | -4.90 | 3.86 | 1.19 |
2024-03-31 | -5.05 | 3.50 | -0.12 |
2023-12-31 | -5.81 | -7.23 | 0.07 |
2023-09-30 | -6.36 | -8.15 | -3.43 |
2023-06-30 | -6.98 | -11.27 | -3.43 |
2023-03-31 | -7.27 | -11.64 | -3.43 |
2022-12-31 | -5.82 | -3.19 | -3.42 |
2022-09-30 | -6.93 | -1.85 | 19.65 |
2022-06-30 | -10.75 | -1.37 | 22.63 |
2022-03-31 | -11.92 | -1.16 | 38.82 |
2021-12-31 | -10.67 | -1.04 | 38.75 |
2021-09-30 | -9.37 | -0.97 | 19.18 |
2021-06-30 | -3.61 | -0.95 | 16.45 |
2021-03-31 | 0.01 | -1.06 | 1.03 |
2020-12-31 | -0.29 | -1.10 | 2.03 |
2020-09-30 | -1.09 | -1.22 | 2.74 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for iSpecimen Inc. as of June 30, 2025 is -0.21.
- The p/book for iSpecimen Inc. as of June 30, 2025 is 1.44.
- The p/tbv for iSpecimen Inc. as of June 30, 2025 is -0.74.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.21 | 1.44 | -0.74 |
2025-03-31 | -0.12 | 0.23 | -0.79 |
2024-12-31 | 0.57 | -1.92 | |
2024-09-30 | -0.31 | 0.53 | -7.67 |
2024-06-30 | -0.30 | 0.51 | -30.72 |
2024-03-31 | 0.22 | 0.84 | |
2023-12-31 | -0.45 | 0.36 | 0.74 |
2023-09-30 | -0.50 | 0.38 | 0.67 |
2023-06-30 | -1.18 | 0.67 | 0.98 |
2023-03-31 | -1.18 | 0.59 | |
2022-12-31 | 0.54 | 0.63 | |
2022-09-30 | 0.58 | 0.65 | |
2022-06-30 | 0.69 | 0.77 | |
2022-03-31 | -5.23 | 1.57 | 1.73 |
2021-12-31 | -8.00 | 5.63 | 7.21 |
2021-09-30 | -4.93 | 3.78 | 5.00 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for iSpecimen Inc. as of June 30, 2025 is -6.92.
- The ebit (3y)/ev for iSpecimen Inc. as of June 30, 2025 is -6.68.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -6.92 | -6.68 |
2025-03-31 | -43.37 | -47.64 |
2024-12-31 | -5.27 | -5.69 |
2024-09-30 | -9.64 | -9.62 |
2024-06-30 | -8.39 | -7.07 |
2024-03-31 | 45.76 | 41.65 |
2023-12-31 | -5.61 | -5.29 |
2023-09-30 | -3.09 | -2.58 |
2023-06-30 | -1.22 | -1.07 |
2023-03-31 | 3.14 | 2.51 |
2022-12-31 | 1.96 | 1.49 |
2022-09-30 | 1.51 | 1.26 |
2022-06-30 | 2.04 | 1.88 |
2022-03-31 | -0.40 | -0.31 |
2021-12-31 | -0.14 | -0.10 |
2021-09-30 | -0.27 | -0.14 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Management Effectiveness
- The roa for iSpecimen Inc. as of June 30, 2025 is -0.95.
- The roe for iSpecimen Inc. as of June 30, 2025 is -1.85.
- The roic for iSpecimen Inc. as of June 30, 2025 is -5.72.
- The croic for iSpecimen Inc. as of June 30, 2025 is -0.66.
- The ocroic for iSpecimen Inc. as of June 30, 2025 is -3.70.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.95 | -1.85 | -5.72 | -0.66 | -3.70 |
2025-03-31 | -0.76 | -1.40 | -1.61 | -0.16 | -0.74 |
2024-12-31 | -0.60 | -0.98 | -1.61 | -0.16 | -0.74 |
2024-09-30 | -0.63 | -0.80 | -1.67 | 0.02 | -0.80 |
2024-06-30 | -0.53 | -0.64 | -1.65 | -0.24 | -0.72 |
2024-03-31 | -0.45 | -0.55 | -1.12 | -1.30 | -0.58 |
2023-12-31 | -0.36 | -0.45 | -0.79 | -1.39 | -0.49 |
2023-09-30 | -0.37 | -0.44 | -0.75 | -1.46 | -0.47 |
2023-06-30 | -0.34 | -0.41 | -0.75 | -1.46 | -0.47 |
2023-03-31 | -0.31 | -0.37 | -0.56 | -1.22 | -0.40 |
2022-12-31 | -0.58 | -0.84 | -0.39 | 0.42 | -0.27 |
2022-09-30 | -0.49 | -0.71 | -0.39 | 0.42 | -0.27 |
2022-06-30 | -0.38 | -0.69 | -0.30 | 0.36 | -0.37 |
2022-03-31 | -1.54 | -0.24 | 0.82 | -0.38 | |
2021-12-31 | -1.37 | -0.27 | 0.81 | -0.60 | |
2021-09-30 | -1.36 | -0.56 | 0.59 | -0.26 | |
2021-06-30 | -1.95 | -0.60 | 0.87 | -0.26 | |
2021-03-31 | -1.66 | ||||
2020-12-31 | -1.10 | ||||
2020-09-30 |
Gross Margins
- The gross margin for iSpecimen Inc. as of June 30, 2025 is 0.38.
- The net margin for iSpecimen Inc. as of June 30, 2025 is -1.40.
- The operating margin for iSpecimen Inc. as of June 30, 2025 is -1.41.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.38 | -1.40 | -1.41 |
2025-03-31 | 0.48 | -0.92 | -0.94 |
2024-12-31 | 0.48 | -0.92 | -0.94 |
2024-09-30 | 0.50 | -0.97 | -0.98 |
2024-06-30 | 0.50 | -1.25 | -1.25 |
2024-03-31 | 0.51 | -1.12 | -1.13 |
2023-12-31 | 0.53 | -0.99 | -1.01 |
2023-09-30 | 0.55 | -1.10 | -1.12 |
2023-06-30 | 0.56 | -1.10 | -1.12 |
2023-03-31 | 0.54 | -0.95 | -0.93 |
2022-12-31 | 0.54 | -1.01 | -1.00 |
2022-09-30 | 0.58 | -1.01 | -1.00 |
2022-06-30 | 0.55 | -0.85 | -0.83 |
2022-03-31 | 0.53 | -0.69 | -0.69 |
2021-12-31 | 0.51 | -0.80 | -0.53 |
2021-09-30 | 0.49 | -0.75 | -0.43 |
2021-06-30 | 0.49 | -0.76 | -0.38 |
2021-03-31 | 0.52 | -0.74 | -0.31 |
2020-12-31 | 0.56 | -0.57 | -0.29 |
2020-09-30 | 0.61 | -0.65 | -0.32 |
Identifiers and Descriptors
Central Index Key (CIK) | 1558569 |
Industry Groups
SIC 8731 - Commercial Physical and Biological Research |